Pfizer to Expand Oncology Business with $43 Billion Acquisition of Biotech Seagen
- March 17, 2023
Pharmaceutical giant Pfizer Inc. is planning to acquire oncology-focused biotechnology firm Seagen Inc. in a deal valued at $43 billion, the companies announced March 13.
ARTICLE TAGS
You must be logged in to access this content.